350 related articles for article (PubMed ID: 33114183)
61. Systematic analysis of the TGF-beta/Smad signalling pathway in the rhabdomyosarcoma cell line RD.
Wang H; Yang GH; Bu H; Zhou Q; Guo LX; Wang SL; Ye L
Int J Exp Pathol; 2003 Jun; 84(3):153-63. PubMed ID: 12974945
[TBL] [Abstract][Full Text] [Related]
62. HER-2 overexpression differentially alters transforming growth factor-beta responses in luminal versus mesenchymal human breast cancer cells.
Wilson CA; Cajulis EE; Green JL; Olsen TM; Chung YA; Damore MA; Dering J; Calzone FJ; Slamon DJ
Breast Cancer Res; 2005; 7(6):R1058-79. PubMed ID: 16457687
[TBL] [Abstract][Full Text] [Related]
63. Inhibiting the TGF-beta signalling pathway as a means of cancer immunotherapy.
Kirkbride KC; Blobe GC
Expert Opin Biol Ther; 2003 Apr; 3(2):251-61. PubMed ID: 12662140
[TBL] [Abstract][Full Text] [Related]
64. Long Non-coding RNA LRNA9884 Promotes Acute Kidney Injury via Regulating NF-kB-Mediated Transcriptional Activation of MIF.
Zhang Y; Tang PM; Niu Y; García Córdoba CA; Huang XR; Yu C; Lan HY
Front Physiol; 2020; 11():590027. PubMed ID: 33192605
[TBL] [Abstract][Full Text] [Related]
65. TGFβ Signaling in the Tumor Microenvironment.
Goulet CR; Pouliot F
Adv Exp Med Biol; 2021; 1270():89-105. PubMed ID: 33123995
[TBL] [Abstract][Full Text] [Related]
66. Regulatory (FoxP3
Koh J; Hur JY; Lee KY; Kim MS; Heo JY; Ku BM; Sun JM; Lee SH; Ahn JS; Park K; Ahn MJ
Sci Rep; 2020 Nov; 10(1):18994. PubMed ID: 33149213
[TBL] [Abstract][Full Text] [Related]
67. Quantifying PD-L1 Expression to Monitor Immune Checkpoint Therapy: Opportunities and Challenges.
Nimmagadda S
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33137949
[TBL] [Abstract][Full Text] [Related]
68. Targeting TGFβ signal transduction for cancer therapy.
Liu S; Ren J; Ten Dijke P
Signal Transduct Target Ther; 2021 Jan; 6(1):8. PubMed ID: 33414388
[TBL] [Abstract][Full Text] [Related]
69. Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways: Challenges and Opportunities.
Hack SP; Zhu AX; Wang Y
Front Immunol; 2020; 11():598877. PubMed ID: 33250900
[TBL] [Abstract][Full Text] [Related]
70. TGF-β1 Signaling: Immune Dynamics of Chronic Kidney Diseases.
Tang PC; Chan AS; Zhang CB; García Córdoba CA; Zhang YY; To KF; Leung KT; Lan HY; Tang PM
Front Med (Lausanne); 2021; 8():628519. PubMed ID: 33718407
[TBL] [Abstract][Full Text] [Related]
71. Smad3 deficiency promotes beta cell proliferation and function in
Sheng J; Wang L; Tang PM; Wang HL; Li JC; Xu BH; Xue VW; Tan RZ; Jin N; Chan TF; Huang XR; Ma RC; Lan HY
Theranostics; 2021; 11(6):2845-2859. PubMed ID: 33456576
[No Abstract] [Full Text] [Related]
72. TGF-β Signaling: From Tissue Fibrosis to Tumor Microenvironment.
Chung JY; Chan MK; Li JS; Chan AS; Tang PC; Leung KT; To KF; Lan HY; Tang PM
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299192
[TBL] [Abstract][Full Text] [Related]
73. Glyoxalase System in Breast and Ovarian Cancers: Role of MEK/ERK/SMAD1 Pathway.
Alhujaily M
Biomolecules; 2024 May; 14(5):. PubMed ID: 38785990
[TBL] [Abstract][Full Text] [Related]
74. The role of tumor-associated macrophages in tumor immune evasion.
Huang R; Kang T; Chen S
J Cancer Res Clin Oncol; 2024 May; 150(5):238. PubMed ID: 38713256
[TBL] [Abstract][Full Text] [Related]
75. The immune regulation and therapeutic potential of the SMAD gene family in breast cancer.
Chen Z; Wang Y; Lu X; Chen H; Kong Y; Rong L; Wang G
Sci Rep; 2024 Mar; 14(1):6769. PubMed ID: 38514720
[TBL] [Abstract][Full Text] [Related]
76. A Comprehensive Review of Platelet-Rich Plasma and Its Emerging Role in Accelerating Bone Healing.
Gharpinde MR; Pundkar A; Shrivastava S; Patel H; Chandanwale R
Cureus; 2024 Feb; 16(2):e54122. PubMed ID: 38487114
[TBL] [Abstract][Full Text] [Related]
77. Doppler ultrasonographic scan, gene expression and serum profile of immune, APPs and antioxidant markers in Egyptian buffalo-cows with clinical endometritis.
El-Sayed A; Refaai M; Ateya A
Sci Rep; 2024 Mar; 14(1):5698. PubMed ID: 38459095
[TBL] [Abstract][Full Text] [Related]
78. Immunotherapy Innovations in the Fight against Osteosarcoma: Emerging Strategies and Promising Progress.
Cheng S; Wang H; Kang X; Zhang H
Pharmaceutics; 2024 Feb; 16(2):. PubMed ID: 38399305
[TBL] [Abstract][Full Text] [Related]
79. Role of Cyclins and Cytoskeletal Proteins in Endometriosis: Insights into Pathophysiology.
Szymański M; Bonowicz K; Antosik P; Jerka D; Głowacka M; Soroka M; Steinbrink K; Kleszczyński K; Gagat M
Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398227
[TBL] [Abstract][Full Text] [Related]
80. Targeting MYC at the intersection between cancer metabolism and oncoimmunology.
Venkatraman S; Balasubramanian B; Thuwajit C; Meller J; Tohtong R; Chutipongtanate S
Front Immunol; 2024; 15():1324045. PubMed ID: 38390324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
